Diagnostic test could help doctors refine prostate cancer treatment

Дата публикации: 24-10-2026 00:40:01

Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer does not behave the same way in every patient, and doctors have long faced a difficult balancing act between identifying patients who will benefit from more intensive treatment and those who may do just as well without it. Treating someone more aggressively than necessary is associated with increased side effects and poorer quality of life.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	“Prostate cancer is asymptomatic; in Malaga we detect 1,200 cases a year”	0	9.26	01-07-2026
2	Del diagnóstico precoz a la medicina de precisión: el cáncer de próstata gana batalla y tiempo de vida a los hombres	0	7	10-06-2026
3	Researchers develop mathematical measures to better personalize therapy for prostate cancer	0	7.4	13-08-2026
4	¿Eyacular 21 veces al mes previene el cáncer de próstata? Esto es lo que dice realmente la ciencia	0	5	19-06-2026
5	For early prostate cancer, 'active surveillance' is now the number 1 choice	0	9.98	13-08-2026
6	«Не только женская проблема»: врач-онколог рассказал о признаках рака груди у мужчин	-1	13.54	21-10-2026
7	Investigational vaccine generates immune response to KRAS mutations in pancreatic cancer study	0	8.43	24-10-2026
8	UMMC’s new cancer center aims to expand access to life-saving care in Mississippi	0	7.83	22-10-2026
9	What women need to know about breast density and how it affects cancer detection	0	5.62	19-10-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 8.09. Источник: medicalxpress.com.